New drug candidate suppresses SARS-CoV-2 replication

Researchers at Stanford University and Utah State University have developed a novel inhibitor of the coronavirus main protease (Mpro) that effectively suppresses the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "New drug candidate suppresses SARS-CoV-2 replication"

Post a Comment